Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
An update on a clinical trial evaluating the efficacy and safety of psychopharmacotherapy in patients with schizophrenia or bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: The Effect of Cigarette Holders, Plastic Menthol Cigarettes, and Cognitive Behavioral Therapy for Smoking Reduction Among Schizophrenia Inpatients: A Comparative Study [NA]
A completed comparative clinical trial in schizophrenia inpatients evaluated strategies to reduce smoking, including cigarette holders, plas…
-
CLINICAL_TRIALS research · 2010-07-22Clinical Trial Update: Family Motivational Intervention in Schizophrenia [NA]
Clinical trial update on a family motivational intervention for individuals with schizophrenia, studied in participants with cannabis use, s…
-
CLINICAL_TRIALS trial_result · 2010-07-20Clinical Trial Update: A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome [Phase 4]
A Phase 4 trial comparing aripiprazole to other atypical antipsychotics in schizophrenic patients with metabolic syndrome was terminated, wi…
-
CLINICAL_TRIALS trial_result · 2010-07-14Clinical Trial Update: Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia [Phase 3]
A Phase 3 extension study evaluating the safety of oral ziprasidone in adults with schizophrenia has completed with results posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-07-08FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone [NA]
This entry describes a clinical trial evaluating the efficacy and safety of a long-acting risperidone microsphere formulation in schizophren…
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics
An observational study analyzing metabolic syndrome parameters in schizophrenia patients treated with atypical antipsychotics; completed wit…
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) [Phase 3]
A completed Phase 3 trial extension evaluating 6 months of asenapine with olanzapine in schizophrenia patients with negative symptoms; resul…
-
CLINICAL_TRIALS trial_result · 2010-06-30Clinical Trial Update: Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients [Phase 2]
A Phase 2 study evaluating the efficacy, safety, and tolerability of AZD8529 in adults with schizophrenia has completed.
-
FDA approval · 2010-06-29FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for risperidone, updating the labeling for this generic product.
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study [Phase 2]
A six-week, randomized, double-blind, placebo-controlled Phase II trial in schizophrenia sponsored by BioLineRx has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020 [Phase 2]
An extension phase 2 study of Bl-1020 in schizophrenia evaluating long-term safety, tolerability, and efficacy at low and high doses.
-
CLINICAL_TRIALS withdrawal · 2010-06-29Clinical Trial Update: Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients [Phase 3]
Phase 3 trial evaluating bexarotene and fenretinide as add-on therapy to antipsychotics in schizophrenia and schizoaffective disorder has be…
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Microglia Activation in Schizophrenia [Phase 1]
Phase 1 clinical trial update on microglia activation in schizophrenia has completed.
-
CLINICAL_TRIALS research · 2010-06-28Clinical Trial Update: Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study
A completed fMRI study examining attention and visual perception in individuals with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-06-23Clinical Trial Update: Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients [Phase 4]
A Phase 4 clinical trial evaluating the effect of olanzapine on sleep EEG in schizophrenia patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-15Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Seroquel (quetiapine) in Chinese Han patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients [Phase 3]
A Phase 3 double-blind, placebo-controlled trial evaluated the safety and efficacy of paliperidone extended-release in adolescents with schi…
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: Quality of Life in Schizophrenic Patients
AstraZeneca completed a clinical trial evaluating quality of life in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-05-28Clinical Trial Update: To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) [Phase 3]
A Phase 3 trial update assessing long-term efficacy and safety of asenapine in schizophrenia has been completed with results posted in 2010.
-
FDA approval · 2010-05-27FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2010-05-27FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) from Eli Lilly and Company.
-
FDA approval · 2010-05-27FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2010-05-25Clinical Trial Update: Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole [NA]
The document describes a clinical trial assessing whether aripiprazole can remediate sensory gating deficits in schizophrenia.